Table 1 Clinicopathological characteristics and URG4 expression in the cervical cancer patients
Number of cases (%) | |
|---|---|
Age, years | |
≥42 | 93 (55.7) |
<42 | 74 (44.3) |
Squamous cell carcinoma antigen, ng/ml | |
≤1.5 | 97 (58.1) |
>1.5 | 51 (30.5) |
No test | 19 (11.4) |
FIGO stage | |
Ib1 | 68 (40.7) |
Ib2 | 59 (35.3) |
IIa1 | 38 (22.8) |
IIa2 | 2 (1.2) |
Tumour size, cm | |
<4 | 106 (63.5) |
≥4 | 61 (36.5) |
Histological type | |
Squamous cell carcinoma | 153 (91.6) |
Adeno cell carcinoma | 14 (8.4) |
Histological differentiation | |
Well | 8 (4.8) |
Moderate | 66 (39.5) |
Poor | 93 (55.7) |
Deep stromal invasion | |
No | 67 (40.1) |
Yes | 100 (59.9) |
Lymphovascular space involvement | |
No | 160 (95.8) |
Yes | 7 (4.2) |
Positive parametrium | |
No | 162 (97) |
Yes | 5 (2.4) |
Positive surgical margin | |
No | 164 (98.2) |
Yes | 3 (1.8) |
Vaginal involvement | |
No | 157 (94.0) |
Yes | 10 (6.0) |
T classification | |
T1b1 | 113 (67.7) |
T1b2 | 39 (23.4) |
T2a | 9 (5.4) |
T2b | 4 (2.4) |
T4 | 2 (1.2) |
N classification | |
N0 | 140 (83.8) |
N1 | 27 (16.2) |
M classification | |
No | 160 (95.8) |
Yes | 7 (4.2) |
Concurrent chemotherapy and radiotherapy | |
No | 59 (62.1) |
Yes | 36 (37.9) |
Radiotherapy | |
No | 49 (68.1) |
Yes | 23 (31.9) |
Recurrence | |
No | 148 (88.6) |
Yes | 19 (11.4) |
Vital status (at follow-up) | |
Alive | 155 (92.8) |
Dead | 12 (7.2) |
URG4 expression | |
Low or no expression | 108 (64.7) |
High expression | 59 (35.3) |
0) | |